HELIX alpha strengthens its European Life Science Real Estate platform
HELIX alpha is further strengthening its European platform and expanding the specialist capabilities it offers across Life Science Real Estate.
As of 1 October 2026, Patrick Schlump will join HELIX alpha as Managing Partner and shareholder, taking a leading role in Fund Management, Client Relations and Equity Raising. Most recently with France-based Praemia REIM, Patrick brings extensive experience in European investment and fund management. He and HELIX alpha founder and CEO Martin Eberhardt have worked together since 2009 across Union Investment, Bouwfonds Investment Management and Swiss Life Asset Managers/Corpus Sireo, including the development, launch and management of institutional real estate investment products.
At the same time, Thomas Diefenthal will move from the Advisory Board into the operational role of Director Advisory. Drawing on more than 30 years of experience in the Life Science and biotechnology ecosystem, including his long-standing leadership of BioPark Regensburg, he will contribute his expertise across HELIX alpha’s Real Estate Asset Management and Advisory activities and join the Investment & Risk Committee.
Investment Management remains at the core of HELIX alpha. At the same time, the platform will now make selected capabilities and expertise developed for its own investment activities available to third parties through its Advisory business.
The new offering will support Life Science corporates, investors, developers and public-sector and cluster organisations across the real estate value chain – from occupier and space requirements and cluster development to Real Estate Asset Management, investment and capital structuring.
This expansion reflects HELIX alpha’s integrated approach to European Life Science Real Estate: combining investment expertise with an in-depth understanding of occupiers, buildings and the ecosystems in which they operate.
The full press release is available here:
.
Kommentare